Flowneuroscience

flowneuroscience.com →

+261%

est. 2Y upside i

Series A

Rank

#48

Sector

Therapeutic Devices

Est. Liquidity

~5Y

Data Quality

Data: Low

Despite the attractive upside from FDA approval and high growth, the analysis has low confidence due to stale financial data and a massive preference overhang (76% of valuation).

Last updated: July 19, 2026

Bull (30%)+380%

FDA approval drives rapid adoption; revenue reaches $11M by mid-2028 and exit multiple holds at 10x, yielding $110M exit. Upside capped at +400% per Series A stage, net of 20% dilution.

Base (45%)+282%

Steady growth with multiple converging to 6x; exit at $66M (302% pre-dilution). After 20% dilution, upside to common is 282%.

Bear (25%)+81%

Multiple compresses to 3x due to competitive pressure or slow adoption; exit at $33M (101% pre-dilution). After 20% dilution, upside is 81%. Preference stack dilutes common further.

Est. time to liquidity~5.0 years

Preference Stack Risk

severe

Funding Intensity

76%

Total preferred funding of $12.5M vs. entry valuation of $16.4M gives a preference overhang of 76%, meaning common equity is heavily subordinated.

Dilution Risk

high

With only $12.5M raised and negative cash flow, a dilutive funding round is likely within 2 years, potentially reducing common ownership by 15-25%.

Secondary Liquidity

none

No secondary market activity reported; employee shares likely illiquid until an exit event.

View all 8 open roles at Flowneuroscience →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Flowneuroscience's data — designed to show you've done your homework.

  • 1

    “How does Flow differentiate from traditional TMS and pharmaceutical treatments in the depression market?”

  • 2

    “What is the target gross margin and capital efficiency as the device scales?”

  • 3

    “What is the vesting schedule and does the company have any secondary liquidity programs for employees?”

Community

Valuation Sentiment

Our model estimates +261% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.